ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-5.4%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$111M
AUM Growth
+$111M
(+44%)
Cap. Flow
+$36.6M
Cap. Flow
% of AUM
32.88%
Top 10 Holdings %
Top 10 Hldgs %
57.45%
Holding
58
New
25
Increased
8
Reduced
9
Closed
12
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$12M |
| 2 |
Thermo Fisher Scientific
TMO
|
$7.01M |
| 3 |
Bruker
BRKR
|
$5.98M |
| 4 |
Avantor
AVTR
|
$4.78M |
| 5 |
CONMED
CNMD
|
$4.23M |
Top Sells
| 1 |
Labcorp
LH
|
$7.86M |
| 2 |
Cigna
CI
|
$5.65M |
| 3 |
Agilent Technologies
A
|
$5.5M |
| 4 |
Becton Dickinson
BDX
|
$3.53M |
| 5 |
Cardinal Health
CAH
|
$3M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Real Estate | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Masimo
MASI
$7.43B
| – | – |
-2,850
| Closed | -$469K |
|
52
Medtronic
MDT
$118B
| – | – |
-27,181
| Closed | -$2.39M |
|
53
Qiagen
QGEN
$10.1B
| – | – |
-62,708
| Closed | -$2.82M |
|
54
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
55
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
0
| – | – |
|
56
Viking Therapeutics
VKTX
$3.02B
| – | – |
-20,754
| Closed | -$336K |
|
57
Ventas
VTR
$30.7B
| – | – |
-41,575
| Closed | -$1.97M |
|
58
Zoetis
ZTS
$67.6B
| – | – |
-7,643
| Closed | -$1.32M |
|